RE: ASCO and pharmacometrics

From: Naoto Hayashi Date: April 08, 2016 technical Source: mail-archive.com
Dear Pascal and Phil, I understand that the big conference would have a higher hurdles for poster session. Even thought, I doubt that ASCO is having intention to select pharmacometrics presentations without enough number of reviewers of pharmacometrics specialist. It was just my first question. I intend to write a paper with the same contents and you would be able to see whether my suspicious was reasonable or not in future. Thanks for your cheering me. Best regards, Naoto
Apr 06, 2016 Naoto Hayashi ASCO and pharmacometrics
Apr 06, 2016 Manish R Sharma Re: ASCO and pharmacometrics
Apr 06, 2016 Joachim Grevel RE: ASCO and pharmacometrics
Apr 06, 2016 Pascal Girard RE: ASCO and pharmacometrics
Apr 06, 2016 Nick Holford Re: ASCO and pharmacometrics
Apr 07, 2016 Phil Lowe RE: ASCO and pharmacometrics
Apr 07, 2016 Dennis Fisher Re: ASCO and pharmacometrics
Apr 07, 2016 Markus Joerger Re: ASCO and pharmacometrics
Apr 07, 2016 Joga Gobburu RE: ASCO and pharmacometrics
Apr 08, 2016 Naoto Hayashi RE: ASCO and pharmacometrics
Apr 08, 2016 Pascal Girard Re: ASCO and pharmacometrics